| Authors: |
Rathi N; Urologic Oncology Branch National Cancer Institute, Bethesda, MD., Blake Z; Urologic Oncology Branch National Cancer Institute, Bethesda, MD., Hyman J; Urologic Oncology Branch National Cancer Institute, Bethesda, MD., Nemirovsky DR; Urologic Oncology Branch National Cancer Institute, Bethesda, MD., Gelikman DG; Urologic Oncology Branch National Cancer Institute, Bethesda, MD; Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD., Hesswani C; Urologic Oncology Branch National Cancer Institute, Bethesda, MD., Koller C; Urologic Oncology Branch National Cancer Institute, Bethesda, MD., Nethala D; Urologic Oncology Branch National Cancer Institute, Bethesda, MD., Mendhiratta N; Urologic Oncology Branch National Cancer Institute, Bethesda, MD., Kenigsberg AP; Urologic Oncology Branch National Cancer Institute, Bethesda, MD., Noun J; Urologic Oncology Branch National Cancer Institute, Bethesda, MD., Dahut W; Urologic Oncology Branch National Cancer Institute, Bethesda, MD; Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD., Karzai FY; Urologic Oncology Branch National Cancer Institute, Bethesda, MD; Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD., Linehan WM; Urologic Oncology Branch National Cancer Institute, Bethesda, MD., Pinto PA; Urologic Oncology Branch National Cancer Institute, Bethesda, MD., Turkbey B; Urologic Oncology Branch National Cancer Institute, Bethesda, MD; Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD., Gurram S; Urologic Oncology Branch National Cancer Institute, Bethesda, MD. Electronic address: Sandeep.gurram@nih.gov. |
